TrialScientific reports2019

Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial.

Emi Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.